Pricing Log in Create free account

Evotec AG (EVO) vs Tilray Brands, Inc. (TLRY)

Evotec AG and Tilray Brands, Inc. are both Drug Manufacturers Specialty & Generic companies. Evotec AG and Tilray Brands, Inc. are of similar size ($504.4M and $474.4M). Tilray Brands, Inc. grew revenue faster over the last twelve months: 15.9% against 2.15%. Tilray Brands, Inc. has the higher net margin (−17.1% vs −26.2%) and the lower return on invested capital (−3.21% vs 0.00%). Across the 18 metrics below, Tilray Brands, Inc. leads on 10 and Evotec AG on 8.

Valuation

Metric EVO TLRY Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 0.57 0.42 2.11
P/B 0.63 0.25 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m n/m 12.58
EV/Sales 0.58 0.56 2.73
Earnings yield (46.23%) (45.40%) (4.38%)
Free cash flow yield (40.86%) (43.04%) 0.00%

Profitability

Metric EVO TLRY Drug Manufacturers Specialty & Generic median
Gross margin 11.42% 29.12% 53.94%
Operating margin (21.35%) (9.26%) 0.00%
Net margin (26.20%) (17.05%) 0.00%
Free cash flow margin 0.00% (18.11%) 0.00%
Return on equity 0.00% (10.50%) (0.40%)
Return on assets 0.00% (7.45%) (3.32%)
Return on invested capital 0.00% (3.21%) 0.00%

Growth

Metric EVO TLRY Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 2.15% 15.93% 10.01%
EPS growth (last fiscal year) 44.89% 95.57% 49.06%
Revenue growth, 5-year CAGR 9.28% 7.82% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EVO TLRY Drug Manufacturers Specialty & Generic median
Debt to equity 0.72 0.22 0.05
Current ratio 2.33 1.88 2.31
Net debt to EBITDA (0.64) 11.34 0.97

Dividend

Metric EVO TLRY Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric EVO TLRY Drug Manufacturers Specialty & Generic median
Market cap 504.36m 474.40m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack